サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563854

敗血症診断薬の世界市場

Sepsis Diagnostics

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
敗血症診断薬の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

敗血症診断薬の世界市場は2030年までに12億米ドルに達する見込み

2023年に6億9,630万米ドルと推定される敗血症診断薬の世界市場は、分析期間2023-2030年にCAGR 7.5%で成長し、2030年には12億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである微生物学技術は、CAGR 9.0%を記録し、分析期間終了時には7億4,980万米ドルに達すると予測されます。イムノアッセイ技術分野の成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は推定1億8,400万米ドル、中国はCAGR12.7%で成長予測

米国の敗血症診断薬市場は、2023年に1億8,400万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを12.7%として、2030年までに2億9,940万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0%と7.4%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界の敗血症診断薬市場- 主要動向と促進要因のまとめ

先進的な敗血症診断薬の需要が急増している理由とは？

敗血症は、感染に対する身体の極端な反応から生じる生命を脅かす病態であり、依然として世界の死亡原因の上位を占めています。患者の予後を改善し、ヘルスケアコストを削減するためには、早期発見とタイムリーな介入が不可欠であるため、先進的な敗血症診断薬に対する需要は急速に高まっています。従来の診断法では、時間的な遅れ、正確さ、敗血症を早期に発見することの複雑さといった課題に直面することが多いです。これに対し、病院や臨床検査室では、敗血症の正確かつ迅速な診断を可能にするため、分子診断、迅速抗原検査、バイオマーカーに基づくアッセイなどの革新的な診断ソリューションの導入が進んでいます。特に集中治療室（ICU）や救急部門における敗血症の有病率の高さが、こうした先進的な診断ツールの世界の普及をさらに後押ししています。

技術の進歩は敗血症診断薬にどのような影響を与えているか？

技術の進歩は、敗血症診断薬の状況を著しく向上させ、より高い精度、スピード、信頼性を提供しています。ポリメラーゼ連鎖反応（PCR）や次世代シークエンシング（NGS）を含む分子診断の革新は、病原体とその抗生物質耐性プロファイルの迅速な同定を可能にし、標的治療を促進しています。さらに、自動化プラットフォームやポイントオブケア（POC）機器の開発により、診断能力がベッドサイドに近づき、結果が出るまでの時間が短縮され、臨床的意思決定が改善されつつあります。AIや機械学習アルゴリズムも診断ツールに組み込まれ、複雑なデータセットを解析し、敗血症の転帰をより正確に予測できるようになっています。さらに、プロカルシトニン（PCT）、CRP、乳酸値などのバイオマーカーに基づく検査の台頭は、臨床医に敗血症の重症度と進行に関する重要な情報を提供し、高度診断薬市場を牽引しています。

敗血症診断薬の採用をリードしている市場セグメンテーションは？

敗血症診断薬市場は、技術、製品タイプ、病原体、検査タイプ、エンドユーザー、地域によって区分されます。主な技術には、分子診断、免疫測定、微生物学、フローサイトメトリーなどがあり、中でも分子診断は迅速かつ正確な病原体同定が可能であるため、市場をリードしています。製品タイプは機器、試薬からソフトウェア、サービスまで多岐にわたるが、試薬と消耗品は定期的な需要により最大のシェアを占めています。敗血症診断薬の対象となる病原体には、細菌性病原体、真菌性病原体、ウイルス性病原体が含まれ、臨床現場での細菌感染の発生率が高いことから、細菌性病原体が最も一般的です。敗血症診断薬のエンドユーザーには、病院、病理検査室、研究機関が含まれ、ICUや救急部での敗血症症例の多さから病院が市場を独占しています。地域的には、北米と欧州が先進的なヘルスケアインフラと高い認知度により主要市場となっている一方、アジア太平洋は医療投資の増加と敗血症に対する意識の高まりにより高成長地域として浮上しています。

敗血症診断薬市場の成長促進要因は？

敗血症診断薬市場の成長は、敗血症の有病率の増加、迅速かつ正確な診断ツールの必要性、分子およびバイオマーカーに基づく診断の進歩など、いくつかの要因によってもたらされます。短時間で高い感度を提供するポイントオブケア機器や自動化プラットフォームの市場開拓が、病院や診断ラボでの市場導入を促進しています。個別化医療や標的療法への注目の高まりは、正確な病原体同定や抗生物質感受性検査を可能にする先進的な敗血症診断薬の使用を拡大しています。敗血症による死亡率の低下や早期発見の向上を目的とした政府の取り組みやヘルスケアプログラムの増加は、市場成長の新たな機会を生み出しています。さらに、新規敗血症バイオマーカー、AIベースの診断ツール、迅速マルチプレックスアッセイに対する研究開発投資の増加が市場拡大をさらに後押ししています。

調査対象企業の例（注目の全46社）

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics（Schweiz）AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP14671

Global Sepsis Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for Sepsis Diagnostics estimated at US$696.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$749.8 Million by the end of the analysis period. Growth in the Immunoassay Technology segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.0 Million While China is Forecast to Grow at 12.7% CAGR

The Sepsis Diagnostics market in the U.S. is estimated at US$184.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$299.4 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Sepsis Diagnostics Market - Key Trends and Drivers Summarized

Why Is the Demand for Advanced Sepsis Diagnostics Growing Rapidly?

Sepsis, a life-threatening condition resulting from the body’s extreme response to infection, remains a leading cause of mortality worldwide. The demand for advanced sepsis diagnostics is rapidly increasing due to the need for early detection and timely intervention, which are critical for improving patient outcomes and reducing healthcare costs. Traditional diagnostic methods often face challenges related to time delays, accuracy, and the complexity of identifying sepsis at an early stage. In response, hospitals and clinical laboratories are increasingly adopting innovative diagnostic solutions, such as molecular diagnostics, rapid antigen tests, and biomarker-based assays, to enable precise and swift diagnosis of sepsis. The high prevalence of sepsis, particularly in intensive care units (ICUs) and emergency departments, is further driving the adoption of these advanced diagnostic tools globally.

How Are Technological Advancements Impacting Sepsis Diagnostics?

Technological advancements are significantly enhancing the sepsis diagnostics landscape, offering greater accuracy, speed, and reliability. Innovations in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), are enabling rapid identification of pathogens and their antibiotic resistance profiles, facilitating targeted therapy. Additionally, the development of automated platforms and point-of-care (POC) devices is bringing diagnostic capabilities closer to the bedside, reducing the time-to-results and improving clinical decision-making. AI and machine learning algorithms are also being integrated into diagnostic tools to analyze complex datasets and predict sepsis outcomes more accurately. Furthermore, the rise of biomarker-based tests, such as procalcitonin (PCT), C-reactive protein (CRP), and lactate levels, is providing clinicians with critical information on the severity and progression of sepsis, driving the market for advanced diagnostics.

Which Market Segments Are Leading the Adoption of Sepsis Diagnostics?

The sepsis diagnostics market is segmented by technology, product type, pathogen, testing type, end-user, and region. Key technologies include molecular diagnostics, immunoassays, microbiology, and flow cytometry, with molecular diagnostics leading due to their rapid and precise pathogen identification capabilities. Product types range from instruments and reagents to software and services, with reagents and consumables accounting for the largest share owing to their recurring demand. Pathogens covered in sepsis diagnostics include bacterial, fungal, and viral pathogens, with bacterial sepsis diagnostics being the most common due to the high incidence of bacterial infections in clinical settings. End-users of sepsis diagnostics include hospitals, pathology labs, and research institutes, with hospitals dominating the market due to the high volume of sepsis cases in ICUs and emergency departments. Geographically, North America and Europe are the leading markets due to advanced healthcare infrastructure and high awareness, while Asia-Pacific is emerging as a high-growth region driven by increasing healthcare investments and rising sepsis awareness.

What Are the Key Drivers of Growth in the Sepsis Diagnostics Market?

The growth in the sepsis diagnostics market is driven by several factors, including the increasing prevalence of sepsis, the need for rapid and accurate diagnostic tools, and advancements in molecular and biomarker-based diagnostics. The development of point-of-care devices and automated platforms that provide quick turnaround times and high sensitivity is driving market adoption across hospitals and diagnostic labs. The growing focus on personalized medicine and targeted therapies is expanding the use of advanced sepsis diagnostics that enable precise pathogen identification and antibiotic susceptibility testing. The rise of government initiatives and healthcare programs aimed at reducing sepsis mortality rates and improving early detection is creating new opportunities for market growth. Additionally, the increasing investments in R&D for novel sepsis biomarkers, AI-based diagnostic tools, and rapid multiplex assays are further supporting market expansion.

Select Competitors (Total 46 Featured) -

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics (Schweiz) AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Sepsis Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sepsis Cases Globally Spurs Demand for Advanced Diagnostic Solutions
    • Technological Advancements in Molecular Diagnostics Propel Innovation in Sepsis Testing
    • Increasing Focus on Early Detection and Rapid Diagnosis Expands Addressable Market Opportunity
    • Growth of Point-of-Care Testing (POCT) for Sepsis Strengthens Business Case for Diagnostic Tools
    • Focus on Enhancing Sensitivity and Specificity of Sepsis Diagnostic Tests Drives Adoption
    • Emergence of Automated and AI-Driven Diagnostic Systems Generates New Market Opportunities
    • Rising Use of Biomarker-Based Diagnostics in Sepsis Detection Boosts Market Potential
    • Shift Towards Personalized Medicine and Targeted Therapies Expands Market Reach
    • Growing Emphasis on Sepsis Management in Critical Care Units Spurs Market Innovation
    • Emergence of Sepsis Diagnostics as a Key Component in Antimicrobial Stewardship Programs Expands Adoption
    • Expansion of Diagnostic Applications in Low- and Middle-Income Countries Creates New Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sepsis Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Molecular Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Blood Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Assay Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Point-of-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • CHINA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • INDIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030

IV. COMPETITION